NCT04297631View on ClinicalTrials.gov

Intraarticular Antibiotic in TKA

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 14, 2020

Primary Completion Date

August 1, 2020

Study Completion Date

November 1, 2020

Conditions
Antibotics in Cementless Knees
Interventions
DRUG

Tobramycin Powder

Everyone gets tobramycin powder.

DEVICE

Vancomyscin

Everyone gets the vancomyscin powder.

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

All Listed Sponsors
lead

Washington University School of Medicine

OTHER

NCT04297631 - Intraarticular Antibiotic in TKA | Biotech Hunter | Biotech Hunter